Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Por um escritor misterioso
Descrição
IJMS, Free Full-Text
Challenges and opportunities in targeting the menin-MLL interaction.
PDF) Menin–MLL1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and Cancers
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
A small molecule inhibitor of the Menin/Kmt2a interaction decreases
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Designed to Kill: Novel Menin-MLL Inhibitors Target MLL-Rearranged Leukemia - ScienceDirect
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo - ScienceDirect
Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax
de
por adulto (o preço varia de acordo com o tamanho do grupo)
